Google DeepMind has unveiled AlphaGenome 2, a significant advancement in AI-driven genetic research. The model was trained on more than 100 million individual cell profiles across 68 different tissue types, giving it an unprecedented understanding of cellular biology.
What AlphaGenome 2 Does
The model predicts how specific DNA variants may affect molecular activity in different cell types and states. This means researchers can use it to prioritize which genetic variants to investigate, potentially accelerating the pace of genetic research dramatically.
Research, Not Clinical
DeepMind emphasizes that AlphaGenome 2 is intended for research purposes, not clinical diagnosis. It's a tool to help scientists narrow down which genetic variants are worth studying further, rather than a diagnostic tool that could be used in a doctor's office.
The announcement follows DeepMind's pattern of releasing powerful biological AI models, including AlphaFold for protein structure prediction. As AI continues to accelerate biological research, the gap between laboratory discoveries and clinical applications may continue to shrink.
